when did semaglutide come on the market Oral A $60 billion industry just

However, it is not proven if this actually leads to better results in humans

Within scientific literature and experimental settings, BPC 157 has attracted attention for studies involving cellular behavior, cell migration, vascular responses, and mechanisms related to tissue repair

Make sure you know the facts

It is prescribed for individuals with a body mass index (BMI) of 30 or greater or those with a BMI between 27 and 30 who have weight-related health conditions, such as high blood pressure or type 2 diabetes Ozempic (Semaglutide) , while effective for weight loss in some clinical trials, is approved in Singapore for diabetes management, not as a dedicated weight loss treatment